Teleflex (NYSE:TFX) Reaches New 1-Year High – Still a Buy?

by · The Cerbat Gem

Shares of Teleflex Incorporated (NYSE:TFX – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $140.80 and last traded at $142.1860, with a volume of 57227 shares trading hands. The stock had previously closed at $136.71.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on TFX shares. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective on the stock in a research report on Monday, April 13th. BMO Capital Markets started coverage on shares of Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 target price for the company. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $140.00 to $160.00 in a research report on Monday, June 8th. Finally, Wall Street Zen lowered shares of Teleflex from a “hold” rating to a “sell” rating in a research note on Saturday. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $148.90.

Get Our Latest Report on TFX

Teleflex Stock Up 5.2%

The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The firm has a market capitalization of $6.37 billion, a P/E ratio of -6.30, a PEG ratio of 1.02 and a beta of 0.82. The firm’s fifty day moving average price is $130.96 and its 200-day moving average price is $121.46.

Teleflex (NYSE:TFX – Get Free Report) last announced its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm’s quarterly revenue was up 32.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Friday, May 22nd. Teleflex’s dividend payout ratio is presently -5.96%.

Hedge Funds Weigh In On Teleflex

Several hedge funds have recently made changes to their positions in the business. Empowered Funds LLC grew its position in Teleflex by 15.8% in the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock worth $233,000 after buying an additional 230 shares during the last quarter. Jane Street Group LLC boosted its stake in shares of Teleflex by 42.6% during the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after acquiring an additional 1,895 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Teleflex by 32.7% during the 2nd quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock worth $1,614,000 after acquiring an additional 3,360 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Teleflex by 1.2% in the 2nd quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock worth $16,040,000 after acquiring an additional 1,659 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Teleflex by 108.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock worth $119,000 after acquiring an additional 521 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

About Teleflex

(Get Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

See Also